postural orthostatic tachycardia syndrome

Search with Google Search with Bing
Information
Disease name
postural orthostatic tachycardia syndrome
Disease ID
DOID:0111154
Description
"A heart conduction disease characterized by orthostatic intolerance that has_material_basis_in heterozygous mutation in the SLC6A2 gene on chromosome 16q12.2." [url:https\://rarediseases.info.nih.gov/diseases/9597/postural-orthostatic-tachycardia-syndrome, url:https\://www.ncbi.nlm.nih.gov/pubmed/23580201]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00962728 Active, not recruiting N/A Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS) July 2009 December 2025
NCT02281097 Active, not recruiting N/A Transdermal Vagal Stimulation for POTS June 2013 December 2025
NCT02196376 Active, not recruiting Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome July 2014 July 2025
NCT05094622 Active, not recruiting N/A Physical Training in Patients With POTS After Covid-19 January 10, 2022 December 2024
NCT01563107 Completed N/A Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome March 2012 December 2020
NCT01617616 Completed Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects March 2012 February 12, 2014
NCT02171988 Completed Phase 4 Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) March 2014 December 2016
NCT04875949 Completed N/A Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB) April 2016 April 2019
NCT06054958 Completed POTS-CFS Study: Orthostatic Intolerance in the Context of Pediatric ME/CFS December 6, 2021 November 22, 2022
NCT01367977 Completed Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life May 2011 April 2015
NCT01547117 Completed N/A Dietary Salt in Postural Tachycardia Syndrome March 2012 December 2021
NCT03974737 Completed CRI in POTS in Adolescents June 1, 2019 September 22, 2020
NCT04345432 Completed N/A Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS) January 2014 September 2017
NCT04603157 Completed N/A Remote Self-training Program for Patients With Postural Orthostatic Tachycardia Syndrome January 1, 2020 February 18, 2022
NCT00728026 Completed Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea June 2008 September 16, 2016
NCT05633407 Completed Phase 2 Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS September 23, 2022 April 18, 2024
NCT03182725 Completed Phase 3 Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome February 6, 2018 May 8, 2020
NCT05404672 Completed N/A Breathing Exercises With And Without Aerobic Training In Patients With Postural Orthostatic Tachycardia Syndrome June 1, 2022 January 15, 2023
NCT03674541 Completed Phase 2 The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome January 14, 2020 December 20, 2021
NCT03930914 Completed N/A Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome November 4, 2019 December 7, 2021
NCT05877534 Enrolling by invitation N/A Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized Controlled Study May 25, 2023 June 1, 2025
NCT02725060 Enrolling by invitation N/A Autoimmune Basis for Postural Tachycardia Syndrome February 2016 December 2024
NCT05914649 Not yet recruiting N/A NC Testing in LC & POTS June 1, 2024 December 31, 2029
NCT05363514 Not yet recruiting Phase 4 Low Dose Naltrexone Use in Patients With POTS January 2025 December 2028
NCT06292104 Recruiting Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS) March 5, 2024 January 2029
NCT04881318 Recruiting N/A Compression Garments in the Community With POTS May 17, 2021 December 31, 2024
NCT05212129 Recruiting N/A Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome April 5, 2021 December 31, 2024
NCT05344599 Recruiting Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome January 19, 2022 June 30, 2024
NCT05741112 Recruiting N/A The Long COVID-19 Wearable Device Study November 16, 2023 December 1, 2025
NCT05923840 Recruiting N/A Chemoreflex and Baroreflex Alterations Causing Postural Tachycardia Syndrome With Orthostatic Hyperpnea and Hypocapnia September 23, 2022 August 31, 2024
NCT05924646 Recruiting N/A CAlgary SAlt for POTS May 7, 2024 December 31, 2028
NCT06133075 Recruiting Phase 2 Using Mirabegron to Increase BP in Patients With POTS December 22, 2023 November 21, 2026
NCT06268288 Recruiting N/A Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS) February 14, 2024 July 2024
NCT00608725 Recruiting N/A Pathophysiology of Orthostatic Intolerance December 1996 December 2025
NCT05454137 Recruiting N/A A Shared Medical Appointment Intervention for Quality of Life Improvement in POTS November 1, 2023 October 1, 2024
NCT05481177 Recruiting Phase 4 Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort June 14, 2023 September 1, 2024
NCT05555771 Recruiting N/A Paediatric Syncope in the Emergency Department September 3, 2022 September 30, 2024
NCT05633693 Recruiting N/A Postural Sway and Counterpressure Maneuvers for Pediatric Syncope April 17, 2023 June 2025
NCT01771484 Terminated Phase 1 High Sodium Diet and External Abdominal Compression in POTS December 2012 January 2017
NCT01978535 Terminated Phase 1/Phase 2 Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS) December 17, 2014 September 8, 2017
NCT03070730 Terminated Phase 1/Phase 2 Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist August 15, 2011 July 28, 2014
NCT00865917 Unknown status Phase 2 Cardiovascular Effects of Selective I(f)-Channel Blockade November 2008 December 2010
NCT04855266 Withdrawn Phase 2 Iron Sucrose in Patients With Iron Deficiency and POTS April 2021 May 2023
NCT03365414 Withdrawn Phase 3 A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS January 2022 March 2024
Disase is a (Disease Ontology)
DOID:10273
Cross Reference ID (Disease Ontology)
GARD:9597
Cross Reference ID (Disease Ontology)
ICD10CM:I95.1
Cross Reference ID (Disease Ontology)
MESH:D054972
Cross Reference ID (Disease Ontology)
MIM:604715
Cross Reference ID (Disease Ontology)
ORDO:443236
Exact Synonym (Disease Ontology)
familial orthostatic tachycardia due to norepinephrine transporter deficiency
Exact Synonym (Disease Ontology)
irritable heart
Exact Synonym (Disease Ontology)
mitral valve prolapse syndrome
Exact Synonym (Disease Ontology)
orhtostatic intolerance
Exact Synonym (Disease Ontology)
orthostatic intolerance due to NET deficiency
Exact Synonym (Disease Ontology)
postural tachycardia syndrome due to NET deficiency
Exact Synonym (Disease Ontology)
soldiers heart
MedGen concept unique identifier (MedGen Concept name)
C1299624
MedGen unique identifier (MedGen Concept name)
226970
MeSH unique ID (MeSH (Medical Subject Headings))
D054972